Gracell Biotechnologies Inc. Quarterly Retained Earnings (Accumulated Deficit) in CNY from Q4 2019 to Q2 2023

Taxonomy & unit
us-gaap: CNY and USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Gracell Biotechnologies Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2019 to Q2 2023.
  • Gracell Biotechnologies Inc. Retained Earnings (Accumulated Deficit) for the quarter ending June 30, 2023 was -¥1.92B, a 45.5% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (CNY)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 -1.92B -601M -45.5% Jun 30, 2023 6-K 2023-08-14
Q4 2022 -1.63B -608M -59.7% Dec 31, 2022 6-K 2023-08-14
Q2 2022 -1.32B Jun 30, 2022 6-K 2022-08-15
Q4 2021 -1.02B -454M -80.4% Dec 31, 2021 20-F 2023-04-25
Q4 2020 -564M -275M -94.9% Dec 31, 2020 20-F 2022-04-22
Q4 2019 -289M Dec 31, 2019 20-F 2021-04-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.